For the quarter ending 2026-03-31, BBOT has $417,646K in assets. $45,366K in debts. $52,658K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 52,658 | 373,687 | 408,741 | |
| Short-term marketable securities | 199,617 | 51,773 | 59,544 | |
| Receivables from related parties | 146 | 386 | 226 | |
| Prepaid expense and other current assets | 14,081 | 6,550 | 7,499 | |
| Total current assets | 266,502 | 432,396 | 476,010 | |
| Long-term marketable securities | 136,617 | - | - | |
| Property and equipment, net | 938 | 956 | 827 | |
| Operating lease right-of-use asset | 2,218 | 2,330 | 2,440 | |
| Other non-current assets | 11,239 | 12,567 | 5,384 | |
| Restricted cash | 132 | 132 | 132 | |
| Total assets | 417,646 | 448,381 | 484,793 | |
| Accounts payable | 12,090 | 1,374 | 3,650 | |
| Accrued compensation and benefits | 2,018 | 5,746 | 4,489 | |
| Accrued research and development liabilities | 25,920 | 25,951 | 24,107 | |
| Accrued professional services | 1,433 | 674 | 2,091 | |
| Payables to related parties | 716 | 534 | 691 | |
| Operating lease liability, current | 538 | 522 | 506 | |
| Other accrued liabilities | 545 | 240 | 178 | |
| Participation right liability | - | 0 | 0 | |
| Total current liabilities | 43,260 | 35,041 | 35,712 | |
| Operating lease liability, noncurrent | 2,106 | 2,244 | 2,381 | |
| Total liabilities | 45,366 | 37,285 | 38,093 | |
| Preference stock, value-Redeemable Convertible Preferred Stock | 0 | 0 | 0 | |
| Preference stock, value-Preferred Stock | 0 | 0 | 0 | |
| Common stock, 0.0001 par value 500,000,000 shares authorized as of march 31, 2026 and december 31, 2025, respectively 80,088,931 and 79,991,768 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 8 | 8 | 8 | |
| Additional paid-in capital | 771,926 | 767,639 | 764,426 | |
| Accumulated deficit | -398,673 | -356,567 | -317,770 | |
| Accumulated other comprehensive income | -981 | 16 | 36 | |
| Total stockholders' equity | 372,280 | 411,096 | 446,700 | |
| Total liabilities, redeemable convertible preferred stock, and stockholders' equity | 417,646 | 448,381 | 484,793 | |
BridgeBio Oncology Therapeutics, Inc. (BBOT)
BridgeBio Oncology Therapeutics, Inc. (BBOT)